Chemours

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Chemical Solutions segment refers to the sale of chemicals used in industrial and consumer applications in the Americas. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Chemours overcomes Q4 challenges, eyes growth and sustainability in 2023

Chemours had a tough Q4 but a successful year overall, with a focus on margin improvement, growth in key businesses, and addressing legacy issues. The company is optimistic about 2023, emphasizing sustainability-led growth and returning value to shareholders.

Chemours reports strong Q1 performance, navigates challenges, eyes growth opportunities

Chemours' Q1 2023 Earnings Call highlighted strong performance, reaffirmed guidance, and emphasized margin improvement strategies. The company faces challenges from macroeconomic uncertainties and inflationary pressures but sees opportunities in sustainable initiatives and market-led innovation. Chemours remains confident in its full-year outlook and growth strategies.

Chemours reports record results, eyes cost reduction and innovation

Chemours had a strong quarter with record results and notable achievements in facility closures and settlements. While challenges lie ahead with a weaker second half expected, the company remains focused on shareholder value and strategic priorities. Opportunities in cost reduction, innovation, and market leadership position Chemours for future growth.

Chemours addresses challenges, eyes growth in sustainable solutions market

Chemours Company navigated challenges in Q3 2023, with a focus on long-term shareholder value and strategic transformation for performance improvement.
Strong performance in Performance Solutions and TSS business, alongside cost savings initiatives, position Chemours for future growth and margin recovery.
Management's commitment to driving value for shareholders amidst industry challenges underscores a proactive approach to addressing market dynamics.

Chemours reports Q4 sales growth, addresses TiO2 market challenges

Chemours is navigating challenges in the TiO2 market while focusing on cost reduction and growth opportunities in other segments. The company aims to maintain competitiveness through strategic decisions and investments in R&D. Analysts' inquiries during the earnings call highlighted concerns about leadership stability and various segment dynamics.

Chemours reports mixed Q1 results, eyes sequential growth in 2024

Chemours' Q1 2024 performance reflected mixed results across segments, with a focus on cost efficiencies, transformation plans, and maintaining liquidity amidst declining net sales and EBITDA.
Despite challenges in certain segments and market uncertainties, Chemours remains optimistic about sequential growth in the second quarter, aiming for significant EBITDA potential in 2024 and long-term financial improvement.
Strategic strengths in cost management, growth initiatives, and market opportunities position Chemours to navigate challenges, drive growth, and enhance profitability in a dynamic business environment.

Chemours exceeds volume expectations amidst challenges, anticipates sequential decline

Chemours demonstrated resilience and growth in key product lines despite facing challenges in Q1 and Q2.
The company's cost-saving efforts and recovery in certain segments highlight its ability to adapt to market conditions.
While financial results were impacted by one-time costs and a decline in net sales, Chemours maintained a strong net leverage ratio.
Anticipated sequential decline in net sales for Q3 underscores the need for strategic planning and operational optimization.

Chemours reports strong Q3 performance amidst strategic growth initiatives

Chemours' Q3 performance reflects operational strength and growth in key segments.
Challenges include declines in net sales for TSS and TT in Q4 and a net loss.
Opportunities exist in cost savings, growth in Opteon refrigerants, and strategic investments.
Overall, Chemours remains confident in its strategy to drive shareholder value.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Other. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Other segment consists of performance chemicals and intermediates business. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

Corteva Inc

DuPont de Nemours

The companies Chemours, DuPont and Corteva announced on Friday they have agreed to pay more than $1 billion to settle claims that "forever chemicals" contaminated public US water systems.

Three chemical giants agree to pay more than $1 billion to settle 'forever chemical' claims

Chemours, along with DuPont and Corteva, have reached a $1.185 billion settlement against charges they polluted groundwater. The case has been a major overhang for Chemours shares.

Why Chemours Stock Is Up Big Today

Chemours Company, DuPont (NYSE:DD) de Nemours, Inc, and Corteva, Inc have jointly announced a settlement agreement in principle to comprehensively resolve all per and polyfluoroalkyl substances (PFAS)-related drinking water claims of a defined class of public water systems that serve the vast majority of the US population. Shares of Chemours soared 25% to $33.93, while DuPont stock rose 6% to $71.60 and Corteva shares gained 3% to $55.30 in Friday morning trading.

Chemours, DuPont, and Corteva shares rally after settlement deal in drinking water claims

The Chemours Co. CC, +2.34%, DuPont de Nemours Inc. DD, +0.37% and Corteva Inc. CTVA, +0.69% announced Friday an “agreement in principle” to settle all drinking water claims related to perfluoroalkyl and polyfluoroalkyl substances, known as PFAS. “The companies deny the allegations in the underlying litigation and reserve all legal and factual defenses against such claims if they were litigated to conclusion,” the companies said in a statement.

Chemours, DuPont and Corteva reach agreement to settle PFAS-related drinking water claims, but deny allegations

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (NYSE: CC), DuPont de Nemours, Inc. (NYSE: DD) and Corteva, Inc. (NYSE: CTVA) (the “companies”) today announced they have reached an agreement in principle to comprehensively resolve all PFAS-related drinking water claims of a defined class of public water systems that serve the vast majority of the United States population. The class includes water systems with a current detection of PFAS1 at any level and those that are currently require.

Chemours, DuPont, and Corteva Reach Comprehensive PFAS Settlement with U.S. Water Systems

WILMINGTON, Del., & NASHVILLE, Tenn.--(BUSINESS WIRE)--The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials has entered into a definitive agreement to sell its Glycolic Acid business (“Glycolic Acid”) for $137 million in cash to PureTech Scientific Inc., a company founded and backed by Iron Path Capital, a private equity firm focused on lower-middle m.

The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc. for $137 Million

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the requisite European Commission and the People's Republic of China State Administration for Market Regulations regulatory approvals are now in place to launch operations at its joint venture with BWT FUMATECH Mobility GmbH (“BWT FUMATECH”), und.

Chemours Officially Launches Operations as Part of Joint Venture with BWT and FUMATECH, Meeting Demand in Mobility Applications Critical to Global, Sustainable Hydrogen Economy

While Chemours (CC) is exposed to headwinds from demand weakness in certain businesses, it gains on healthy Opteon adoption and its pricing actions.

Here's Why You Should Hold Onto Chemours (CC) Stock for Now

Chemours (CC) offers a portfolio of HFO-1336mzzZ-based products that are more environmentally friendly than non-HFO alternatives.

Chemours (CC) Extends Capacity to Meet Customers' Needs

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced a capacity investment in its low global warming potential (GWP) Opteon™ 1100 foam blowing agent and Opteon™ SF33 specialty fluid. The expansion will triple capacity of the ultra-low GWP, hydrofluoroolefin (HFO) solution, enabling customers and va.

Chemours Announces Opteon™ 1100 and Opteon™ SF33 Capacity Expansion to Meet Long-Term Customer Needs for Low Global Warming Potential, High-Performance Solutions

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the resignation of Alisha Bellezza, President, Thermal & Specialized Solutions (TSS), effective May 31. Chemours will run a comprehensive search for Bellezza's replacement. On June 1, stepping in as interim leader is Joseph (Joe) Martinko, Se.

Chemours Thermal & Specialized Solutions President Resigns; Chemours Begins Talent Search for Backfill & Appoints Interim Leader

Lower volumes and currency headwinds on a year-over-year basis, partly offset by higher pricing, impact Chemours' (CC) results in the first quarter.

Chemours' (CC) Q1 Earnings Beat Estimates, Revenues Lag

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Chemours (CC) Right Now?

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today introduces Ti-Pure™ TS-6700, a high-performance, TMP- and TME-free TiO2 grade designed for waterborne architectural coatings applications. Designed to meet the emerging sustainability requirements facing coating producers, Ti-Pure™ TS-6700 is TMP- and TME-.

Chemours Launches Ti-Pure™ TS-6700 to Help Coatings Producers Comply with Evolving Regulations

Chemours is a company I've been covering for years. Challenges remain, but my long-term view for the business is a positive one. I maintain a position in CC. In this article, we'll do an update and see if the PT warrants a slight adjustment based on recent results and current global trends.

Chemours - There Is Upside After A Drop In Share Price

The Chemours Company (NYSE:CC ) Q1 2023 Results Conference Call April 28, 2023 8:00 AM ET Company Participants Jonathan Lock - SVP and Chief Development Officer Mark Newman - CEO, President and Director Sameer Ralhan - Senior VP and CFO Conference Call Participants Duffy Fischer - Goldman Sachs Hassan Ahmed - Alembic Global Advisors John McNulty - BMO Capital Markets James Cannon - UBS Arun Viswanathan - RBC Capital Markets John Roberts - Credit Suisse William Tang - Morgan Stanley Laurence Alexander - Jefferies Matthew DeYoe - Bank of America Operator Good morning, and welcome to the Chemours Company First Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference call is being recorded.

The Chemours Company (CC) Q1 2023 Earnings Call Transcript

While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Chemours (CC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Chemours (CC) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $1.46 per share a year ago.

Chemours (CC) Surpasses Q1 Earnings Estimates

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (TT), Thermal & Specialized Solutions (TSS), and Advanced Performance Materials (APM), today announced its financial results for the first quarter 2023. First Quarter 2023 Results & Highlights Net Sales of $1.5 billion Net Income of $145 million with EPS1 of $0.96 Adjusted Net Income* of $148 million with Adjusted EPS* of $0.9.

The Chemours Company Reports First Quarter 2023 Results

Microsoft

Newmont Mining

Tesla

Caterpillar

Diamondback Energy

Hawaiian Hlds

Meme stocks are a relatively recent phenomenon, having started in 2020. However, the underlying idea of investing in attention-grabbing, risky stocks is nothing new.

7 Best Meme Stocks to Buy for 2023

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company, and TC Energy, a leader in the responsible development and reliable operation of North American energy infrastructure, have executed a memorandum of understanding (MOU) for the potential development of two electrolysis-based hydrogen production facilities at or near Chemours' Washington Works and Belle manufacturing sites in West Virginia.

Chemours and TC Energy Collaborate on the Development of Two Clean Hydrogen Production Facilities in West Virginia

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, was honored yesterday with two awards from the U.S. Department of Energy (DOE) through its Better Buildings, Better Plants Initiative, recognizing partners for outstanding accomplishments in energy efficiency and emissions reduction.

Chemours Receives Two Awards from U.S. Department of Energy's Better Plants Program

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announces the appointment of Amber Wellman, Ph.D., to Chief Sustainability Officer.

Chemours Appoints Dr. Amber Wellman to Chief Sustainability Officer

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announced it will release first quarter 2023 financial results after market close on April 27, 2023. The company will conduct its first quarter 2023 webcast conference call on Friday, April 28, 2023, at 8:00 a.m. Eastern Daylight Time.

Chemours Announces Dates for First Quarter 2023 Earnings Release and Webcast Conference Call

The Beachbody Co.

Nokia

Planet Labs

PayPal

LiveRamp Holdings Inc

Snowflake

If the Covid-19 pandemic taught us anything, it's that investors should never underestimate the power of coordinated trading action via social media, which brings up the topic of super speculative meme stocks. Obviously, this subsegment is highly volatile and should only be approached with money you can afford to lose.

News for Chemours Stock (CC)